Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015 (2015), Article ID 930157, 11 pages
http://dx.doi.org/10.1155/2015/930157
Review Article

Regulators of Actin Dynamics in Gastrointestinal Tract Tumors

Gerhard Domagk Institute of Pathology, University Hospital Münster, 48149 Münster, Germany

Received 15 March 2015; Revised 9 July 2015; Accepted 21 July 2015

Academic Editor: Charles Honore

Copyright © 2015 Konrad Steinestel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Blanchoin, R. Boujemaa-Paterski, C. Sykes, and J. Plastino, “Actin dynamics, architecture, and mechanics in cell motility,” Physiological Reviews, vol. 94, no. 1, pp. 235–263, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. H. N. Higgs, “Discussing the morphology of actin filaments in lamellipodia,” Trends in Cell Biology, vol. 21, no. 1, pp. 2–4, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. K. C. Holmes, D. Popp, W. Gebhard, and W. Kabsch, “Atomic model of the actin filament,” Nature, vol. 347, no. 6288, pp. 44–49, 1990. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Gerhardt, M. Golding, M. Fruttiger et al., “VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia,” The Journal of Cell Biology, vol. 161, no. 6, pp. 1163–1177, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Q. Zheng, J.-J. Wan, and M.-M. Poo, “Essential role of filopodia in chemotropic turning of nerve growth cone induced by a glutamate gradient,” Journal of Neuroscience, vol. 16, no. 3, pp. 1140–1149, 1996. View at Google Scholar · View at Scopus
  6. K. Kalil and E. W. Dent, “Touch and go: guidance cues signal to the growth cone cytoskeleton,” Current Opinion in Neurobiology, vol. 15, no. 5, pp. 521–526, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Blanchoin and T. D. Pollard, “Hydrolysis of ATP by polymerized actin depends on the bound divalent cation but not profilin,” Biochemistry, vol. 41, no. 2, pp. 597–602, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. T. D. Pollard, L. Blanchoin, and R. D. Mullins, “Molecular mechanisms controlling actin filament dynamics in nonmuscle cells,” Annual Review of Biophysics and Biomolecular Structure, vol. 29, pp. 545–576, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. K. G. Campellone and M. D. Welch, “A nucleator arms race: cellular control of actin assembly,” Nature Reviews Molecular Cell Biology, vol. 11, no. 4, pp. 237–251, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Le Clainche and M.-F. Carlier, “Regulation of actin assembly associated with protrusion and adhesion in cell migration,” Physiological Reviews, vol. 88, no. 2, pp. 489–513, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. L. M. Machesky and A. Li, “Invasive filopodia promoting metastasis,” Communicative and Integrative Biology, vol. 3, no. 3, pp. 263–270, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. J. C. Adams, J. D. Clelland, G. D. M. Collett, F. Matsumura, S. Yamashiro, and L. Zhang, “Cell-matrix adhesions differentially regulate fascin phosphorylation,” Molecular Biology of the Cell, vol. 10, no. 12, pp. 4177–4190, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. A. J. Ridley, “Life at the leading edge,” Cell, vol. 145, no. 7, pp. 1012–1022, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Friedl and D. Gilmour, “Collective cell migration in morphogenesis, regeneration and cancer,” Nature Reviews Molecular Cell Biology, vol. 10, no. 7, pp. 445–457, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. T. D. Pollard, “Regulation of actin filament assembly by Arp2/3 complex and formins,” Annual Review of Biophysics and Biomolecular Structure, vol. 36, pp. 451–477, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. D. Rotty, C. Wu, and J. E. Bear, “New insights into the regulation and cellular functions of the ARP2/3 complex,” Nature Reviews Molecular Cell Biology, vol. 14, no. 1, pp. 7–12, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. A. M. Weaver, A. V. Karginov, A. W. Kinley et al., “Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation,” Current Biology, vol. 11, no. 5, pp. 370–374, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Linder, “Invadosomes at a glance,” Journal of Cell Science, vol. 122, no. 17, pp. 3009–3013, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Schoumacher, D. Louvard, and D. Vignjevic, “Cytoskeleton networks in basement membrane transmigration,” European Journal of Cell Biology, vol. 90, no. 2-3, pp. 93–99, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Linder and P. Kopp, “Podosomes at a glance,” Journal of Cell Science, vol. 118, no. 10, pp. 2079–2082, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Dovas and D. Cox, “Regulation of WASp by phosphorylation: activation or other functions?” Communicative and Integrative Biology, vol. 3, no. 2, pp. 101–105, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C. C. Beltzner and T. D. Pollard, “Identification of functionally important residues of Arp2/3 complex by analysis of homology models from diverse species,” Journal of Molecular Biology, vol. 336, no. 2, pp. 551–565, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. L. L. LeClaire III, M. Baumgartner, J. H. Iwasa, R. D. Mullins, and D. L. Barber, “Phosphorylation of the Arp2/3 complex is necessary to nucleate actin filaments,” The Journal of Cell Biology, vol. 182, no. 4, pp. 647–654, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. H.-C. Zheng, Y.-S. Zheng, X.-H. Li et al., “Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma,” Anticancer Research, vol. 28, no. 4, pp. 2225–2232, 2008. View at Google Scholar · View at Scopus
  25. A. Kaneda, M. Kaminishi, Y. Nakanishi, T. Sugimura, and T. Ushijima, “Reduced expression of the insulin-induced protein 1 and p41 Arp2/3 complex genes in human gastric cancers,” International Journal of Cancer, vol. 100, no. 1, pp. 57–62, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Kaneda, M. Kaminishi, T. Sugimura, and T. Ushijima, “Decreased expression of the seven ARP2/3 complex genes in human gastric cancers,” Cancer Letters, vol. 212, no. 2, pp. 203–210, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Su, P. J. M. Ceponis, and P. M. Sherman, “Cytoskeletal rearrangements in gastric epithelial cells in response to Helicobacter pylori infection,” Journal of Medical Microbiology, vol. 52, no. 10, pp. 861–867, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. K. M. Bourzac, C. M. Botham, and K. Guillemin, “Helicobacter pylori CagA induces AGS cell elongation through a cell retraction defect that is independent of Cdc42, Rac1, and Arp2/3,” Infection and Immunity, vol. 75, no. 3, pp. 1203–1213, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Otsubo, K. Iwaya, Y. Mukai et al., “Involvement of Arp2/3 complex in the process of colorectal carcinogenesis,” Modern Pathology, vol. 17, no. 4, pp. 461–467, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Iwaya, K. Oikawa, S. Semba et al., “Correlation between liver metastasis of the colocalization of actin-related protein 2 and 3 complex and WAVE2 in colorectal carcinoma,” Cancer Science, vol. 98, no. 7, pp. 992–999, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Laurila, K. Savinainen, R. Kuuselo, R. Karhu, and A. Kallioniemi, “Characterization of the 7q21q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer,” Genes Chromosomes and Cancer, vol. 48, no. 4, pp. 330–339, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. H. E. Rauhala, S. Teppo, S. Niemelä, and A. Kallioniemi, “Silencing of the arp2/3 complex disturbs pancreatic cancer cell migration,” Anticancer Research, vol. 33, no. 1, pp. 45–52, 2013. View at Google Scholar · View at Scopus
  33. E. D. Goley and M. D. Welch, “The ARP2/3 complex: an actin nucleator comes of age,” Nature Reviews Molecular Cell Biology, vol. 7, no. 10, pp. 713–726, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. J. C. Adams, “Roles of fascin in cell adhesion and motility,” Current Opinion in Cell Biology, vol. 16, no. 5, pp. 590–596, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Hashimoto, T. Ito, H. Inoue et al., “Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma,” Clinical Cancer Research, vol. 11, no. 7, pp. 2597–2605, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. X. Li, H. Zheng, T. Hara et al., “Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas,” International Journal of Oncology, vol. 33, no. 1, pp. 69–79, 2008. View at Google Scholar · View at Scopus
  37. Y. Hashimoto, M. Skacel, I. C. Lavery, A. L. Mukherjee, G. Casey, and J. C. Adams, “Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas,” BMC Cancer, vol. 6, no. 1, article 241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Yamaguchi, T. Inoue, T. Eguchi et al., “Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade,” Modern Pathology, vol. 20, no. 5, pp. 552–561, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Iguchi, S. Aishima, K. Umeda et al., “Fascin expression in progression and prognosis of hepatocellular carcinoma,” Journal of Surgical Oncology, vol. 100, no. 7, pp. 575–579, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. K. E. Prehoda, J. A. Scott, R. D. Mullins, and W. A. Lim, “Integration of multiple signals through cooperative regulation of the N-WASP-Arp2/3 complex,” Science, vol. 290, no. 5492, pp. 801–806, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. M. J. Massaad, N. Ramesh, and R. S. Geha, “Wiskott-Aldrich syndrome: a comprehensive review,” Annals of the New York Academy of Sciences, vol. 1285, no. 1, pp. 26–43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. W.-S. Wang, H.-J. Zhong, D.-W. Xiao et al., “The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features,” Diseases of the Esophagus, vol. 23, no. 6, pp. 512–521, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Hatakeyama, “Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis,” Cell Host & Microbe, vol. 15, no. 3, pp. 306–316, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. T. A. Martin, A.-M. Toms, L. M. Davies, S. Cheng, and W. G. Jiang, “The clinical and biological implications of N-WASP expression in human colorectal cancer,” Translational Gastrointestinal Cancer, vol. 1, no. 1, pp. 10–20, 2011. View at Google Scholar
  45. R. Yanagawa, Y. Furukawa, T. Tsunoda et al., “Genome-wide screening of genes showing altered expression in liver metastases of human colorectal cancers by cDNA microarray,” Neoplasia, vol. 3, no. 5, pp. 395–401, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. J.-C. Guo, J. Li, Y.-P. Zhao et al., “N-WASP in pancreatic ductal adenocarcinoma: associations with perineural invasion and poor prognosis,” World Journal of Surgery, vol. 38, no. 8, pp. 2126–2131, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. K.-M. Jin, M. Lu, F.-F. Liu, J. Gu, X.-J. Du, and B.-C. Xing, “N-WASP is highly expressed in hepatocellular carcinoma and associated with poor prognosis,” Surgery, vol. 153, no. 4, pp. 518–525, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. A. J. Davidson and R. H. Insall, “SCAR/WAVE: a complex issue,” Communicative & Integrative Biology, vol. 6, no. 6, Article ID e27033, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Eden, R. Rohatgi, A. V. Podtelejnikov, M. Mann, and M. W. Kirschner, “Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck,” Nature, vol. 418, no. 6899, pp. 790–793, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Innocenti, A. Zucconi, A. Disanza et al., “Abi1 is essential for the formation and activation of a WAVE2 signalling complex,” Nature Cell Biology, vol. 6, no. 4, pp. 319–327, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Kunda, G. Craig, V. Dominguez, and B. Baum, “Abi, Sra1, and Kette control the stability and localization of SCAR/WAVE to regulate the formation of actin-based protrusions,” Current Biology, vol. 13, no. 21, pp. 1867–1875, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. N. Ibarra, S. L. Blagg, F. Vazquez, and R. H. Insall, “Nap1 regulates Dictyostelium cell motility and adhesion through SCAR-dependent and -independent pathway,” Current Biology, vol. 16, no. 7, pp. 717–722, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Jia, Y. Jia, H. P. Weeks et al., “Down-regulation of WAVE2, WASP family verprolin-homologous protein 2, in gastric cancer indicates lymph node metastasis and cell migration,” Anticancer Research, vol. 34, no. 5, pp. 2185–2194, 2014. View at Google Scholar · View at Scopus
  54. Q. Yao, Z. Cao, C. Tu, Y. Zhao, H. Liu, and S. Zhang, “MicroRNA-146a acts as a metastasis suppressor in gastric cancer by targeting WASF2,” Cancer Letters, vol. 335, no. 1, pp. 219–224, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. Z. Yue, W. Feng, L. Xiangke, W. Liuxing, F. Qingxia, and G. Jianbo, “WAVE3 promotes epithelial–mesenchymal transition of gastric cancer through upregulation of Snail,” Cancer Gene Therapy, vol. 21, no. 12, pp. 499–506, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. H. Ueno, J. Murphy, J. R. Jass, H. Mochizuki, and I. C. Talbot, “Tumour ‘budding’ as an index to estimate the potential of aggressiveness in rectal cancer,” Histopathology, vol. 40, no. 2, pp. 127–132, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. L.-Y. Yang, Y.-M. Tao, D.-P. Ou, W. Wang, Z.-G. Chang, and F. Wu, “Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma,” Clinical Cancer Research, vol. 12, no. 19, pp. 5673–5679, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Kurisu and T. Takenawa, “WASP and WAVE family proteins: friends or foes in cancer invasion?” Cancer Science, vol. 101, no. 10, pp. 2093–2104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. E. S. Clark, A. S. Whigham, W. G. Yarbrough, and A. M. Weaver, “Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia,” Cancer Research, vol. 67, no. 9, pp. 4227–4235, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Oser, H. Yamaguchi, C. C. Mader et al., “Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation,” The Journal of Cell Biology, vol. 186, no. 4, pp. 571–587, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. T. Uruno, J. Liu, Y. Li, N. Smith, and X. Zhan, “Sequential interaction of actin-related proteins 2 and 3 (Arp2/3) complex with neural Wiscott-Aldrich syndrome protein (N-WASP) and cortactin during branched actin filament network formation,” The Journal of Biological Chemistry, vol. 278, no. 28, pp. 26086–26093, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. A. W. Kinley, S. A. Weed, A. M. Weaver et al., “Cortactin interacts with WIP in regulating Arp2/3 activation and membrane protrusion,” Current Biology, vol. 13, no. 5, pp. 384–393, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. X. Sun, C. Li, C. Zhuang et al., “Abl interactor 1 regulates Src-Id1-matrix metalloproteinase 9 axis and is required for invadopodia formation, extracellular matrix degradation and tumor growth of human breast cancer cells,” Carcinogenesis, vol. 30, no. 12, pp. 2109–2116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. C. C. Mader, M. Oser, M. A. O. Magalhaes et al., “An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion,” Cancer Research, vol. 71, no. 5, pp. 1730–1741, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. N. S. Bryce, E. S. Clark, J. L. Leysath, J. D. Currie, D. J. Webb, and A. M. Weaver, “Cortactin promotes cell motility by enhancing lamellipodial persistence,” Current Biology, vol. 15, no. 14, pp. 1276–1285, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. S. Myllykangas, T. Böhling, and S. Knuutila, “Specificity, selection and significance of gene amplifications in cancer,” Seminars in Cancer Biology, vol. 17, no. 1, pp. 42–55, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. K.-F. Hsu, C.-K. Lin, C.-P. Yu et al., “Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma,” Diseases of the Esophagus, vol. 22, no. 5, pp. 402–408, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. N. Y. Hsu, K. T. Yeh, I. P. Chiang, L. Y. Pai, C. Y. Chen, and H.-C. Ho, “Cortactin overexpression in the esophageal squamous cell carcinoma and its involvement in the carcinogenesis,” Diseases of the Esophagus, vol. 21, no. 5, pp. 402–408, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. M.-L. Luo, X.-M. Shen, Y. Zhang et al., “Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance,” Cancer Research, vol. 66, no. 24, pp. 11690–11699, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. X.-L. Du, H. Yang, S.-G. Liu et al., “Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3–CTTN–Akt pathway in esophageal squamous cell carcinoma,” Oncogene, vol. 28, no. 42, pp. 3714–3722, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. C.-M. Su, Y.-H. Su, C.-F. Chiu et al., “Vascular endothelial growth factor-C upregulates cortactin and promotes metastasis of esophageal squamous cell carcinoma,” Annals of Surgical Oncology, vol. 21, supplement 4, pp. S767–S775, 2014. View at Publisher · View at Google Scholar · View at Scopus
  72. G. Cen, H.-H. Ding, B. Liu, and W.-D. Wu, “FBXL5 targets cortactin for ubiquitination-mediated destruction to regulate gastric cancer cell migration,” Tumor Biology, vol. 35, no. 9, pp. 8633–8638, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. W.-C. Tsai, J.-S. Jin, W.-K. Chang et al., “Association of cortactin and fascin-1 expression in gastric adenocarcinoma: correlation with clinicopathological parameters,” Journal of Histochemistry & Cytochemistry, vol. 55, no. 9, pp. 955–962, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. X. Wang, W. Cao, M. Mo, W. Wang, H. Wu, and J. Wang, “VEGF and cortactin expression are independent predictors of tumor recurrence following curative resection of gastric cancer,” Journal of Surgical Oncology, vol. 102, no. 4, pp. 325–330, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. J. Wei, Z.-X. Zhao, Y. Li, Z.-Q. Zhou, and T.-G. You, “Cortactin expression confers a more malignant phenotype to gastric cancer SGC-7901 cells,” World Journal of Gastroenterology, vol. 20, no. 12, pp. 3287–3300, 2014. View at Publisher · View at Google Scholar · View at Scopus
  76. Y.-Y. Lee, C.-P. Yu, C.-K. Lin et al., “Expression of survivin and cortactin in colorectal adenocarcinoma: association with clinicopathological parameters,” Disease Markers, vol. 26, no. 1, pp. 9–18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. H. van Damme, H. Brok, E. Schuuring-Scholtes, and E. Schuuring, “The redistribution of cortactin into cell-matrix contact sites in human carcinoma cells with 11q13 amplification is associated with both overexpression and post-translational modification,” The Journal of Biological Chemistry, vol. 272, no. 11, pp. 7374–7380, 1997. View at Publisher · View at Google Scholar · View at Scopus
  78. J.-H. Cai, R. Zhao, J.-W. Zhu et al., “Expression of cortactin correlates with a poor prognosis in patients with stages II-III colorectal adenocarcinoma,” Journal of Gastrointestinal Surgery, vol. 14, no. 8, pp. 1248–1257, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. Y. N. Kim, J. E. Choi, J. S. Bae et al., “Expression of cortactin and focal adhesion kinase in colorectal adenocarcinoma: correlation with clinicopathologic parameters and their prognostic implication,” Korean Journal of Pathology, vol. 46, no. 5, pp. 454–462, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. H. Hirakawa, K. Shibata, and T. Nakayama, “Localization of cortactin is associated with colorectal cancer development,” International Journal of Oncology, vol. 35, no. 6, pp. 1271–1276, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. K. Steinestel, S. Brüderlein, J. K. Lennerz et al., “Expression and Y435-phosphorylation of Abelson interactor 1 (Abi1) promotes tumour cell adhesion, extracellular matrix degradation and invasion by colorectal carcinoma cells,” Molecular Cancer, vol. 13, no. 1, article 145, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. X. Huang, J. Ji, H. Xue et al., “Fascin and cortactin expression is correlated with a poor prognosis in hepatocellular carcinoma,” European Journal of Gastroenterology & Hepatology, vol. 24, no. 6, pp. 633–639, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. M. Chuma, M. Sakamoto, J. Yasuda et al., “Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma,” Journal of Hepatology, vol. 41, no. 4, pp. 629–636, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. Z. Gang, K. Ya-Lin, W. Dong-Qing, L. Yu, R. Li, and Z. Hong-Yi, “Combining cortactin and CTTN detection with clinicopathologic features increases effectiveness of survival predictions for patients with resectable hepatocellular carcinoma,” Clinical Laboratory, vol. 59, no. 11-12, pp. 1343–1352, 2013. View at Publisher · View at Google Scholar · View at Scopus
  85. D. Jia, Y. Jing, Z. Zhang et al., “Amplification of MPZL1/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma,” Cell Research, vol. 24, no. 2, pp. 204–217, 2014. View at Publisher · View at Google Scholar · View at Scopus
  86. W.-C. Tsai, C.-K. Lin, H.-S. Lee et al., “The correlation of cortactin and fascin-1 expression with clinicopathological parameters in pancreatic and ampulla of Vater adenocarcinoma,” APMIS, vol. 121, no. 3, pp. 171–181, 2013. View at Publisher · View at Google Scholar · View at Scopus
  87. H. M. Kocher, J. Sandle, T. A. Mirza, N. F. Li, and I. R. Hart, “Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells,” Gut, vol. 58, no. 2, pp. 271–284, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. M. Innocenti, E. Frittoli, I. Ponzanelli et al., “Phosphoinositide 3-kinase activates Rac by entering in a complex with Eps8, Abi1, and Sos-1,” The Journal of Cell Biology, vol. 160, no. 1, pp. 17–23, 2003. View at Publisher · View at Google Scholar · View at Scopus
  89. K. D. Courtney, M. Grove, H. Vandongen, A. Vandongen, A.-S. LaMantia, and A. M. Pendergast, “Localization and phosphorylation of Abl-interactor proteins, Abi-1 and Abi-2, in the developing nervous system,” Molecular and Cellular Neurosciences, vol. 16, no. 3, pp. 244–257, 2000. View at Publisher · View at Google Scholar · View at Scopus
  90. M. Innocenti, S. Gerboth, K. Rottner et al., “Abi1 regulates the activity of N-WASP and WAVE in distinct actin-based processes,” Nature Cell Biology, vol. 7, no. 10, pp. 969–976, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. J. R. Ryu, A. Echarri, R. Li, and A. M. Pendergast, “Regulation of cell-cell adhesion by Abi/Diaphanous complexes,” Molecular and Cellular Biology, vol. 29, no. 7, pp. 1735–1748, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. H. Chen, X. Wu, Z. K. Pan, and S. Huang, “Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis,” Cancer Research, vol. 70, no. 23, pp. 9979–9990, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. C. Wang, D. Tran-Thanh, J. C. Moreno et al., “Expression of Abl interactor 1 and its prognostic significance in breast cancer: a tissue-array-based investigation,” Breast Cancer Research and Treatment, vol. 129, no. 2, pp. 373–386, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. N. Hirao, S. Sato, T. Gotoh et al., “NESH (Abi-3) is present in the Abi/WAVE complex but does not promote c-Abl-mediated phosphorylation,” FEBS Letters, vol. 580, no. 27, pp. 6464–6470, 2006. View at Publisher · View at Google Scholar · View at Scopus
  95. R. A. Baba, H. F. Bhat, L. A. Wani et al., “E3B1/ABI-1 isoforms are down-regulated in cancers of human gastrointestinal tract,” Disease Markers, vol. 32, no. 4, pp. 273–279, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. K. Steinestel, S. Brüderlein, J. Steinestel et al., “Expression of abelson interactor 1 (Abi1) correlates with inflammation, kras mutation and adenomatous change during colonic carcinogenesis,” PLoS ONE, vol. 7, no. 7, Article ID e40671, 2012. View at Publisher · View at Google Scholar · View at Scopus
  97. Z. Kanaan, M. Qadan, M. R. Eichenberger, and S. Galandiuk, “The actin-cytoskeleton pathway and its potential role in inflammatory bowel disease-associated human colorectal cancer,” Genetic Testing and Molecular Biomarkers, vol. 14, no. 3, pp. 347–353, 2010. View at Publisher · View at Google Scholar · View at Scopus
  98. P. Kiely, J. Tod, V. Jenei, C. Johnson, and G. J. Thomas, “OC-043 the role of the EPS8 binding partners Sos1 and Abi1 in pancreatic cancer,” Gut, vol. 62, supplement 1, article A19, 2013. View at Publisher · View at Google Scholar
  99. J. Tod, V. Jenei, M. Chrzan, C. Johnson, D. Fine, and G. Thomas, “Role of EPS8 in integrin-dependent pancreatic cancer invasion,” The Lancet, vol. 383, article S101, 2014. View at Publisher · View at Google Scholar
  100. A. Nürnberg, T. Kitzing, and R. Grosse, “Nucleating actin for invasion,” Nature Reviews Cancer, vol. 11, no. 3, pp. 117–187, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. I. Ichetovkin, W. Grant, and J. Condeelis, “Cofilin produces newly polymerized actin filaments that are preferred for dendritic nucleation by the Arp2/3 complex,” Current Biology, vol. 12, no. 1, pp. 79–84, 2002. View at Publisher · View at Google Scholar · View at Scopus
  102. W. Wang, R. Eddy, and J. Condeelis, “The cofilin pathway in breast cancer invasion and metastasis,” Nature Reviews Cancer, vol. 7, no. 6, pp. 429–440, 2007. View at Publisher · View at Google Scholar · View at Scopus
  103. Y.-J. Lee, D. J. Mazzatti, Z. Yun, and P. C. Keng, “Inhibition of invasiveness of human lung cancer cell line H1299 by over-expression of cofilin,” Cell Biology International, vol. 29, no. 11, pp. 877–883, 2005. View at Publisher · View at Google Scholar · View at Scopus
  104. H. Pawar, M. K. Kashyap, N. A. Sahasrabuddhe et al., “Quantitative tissue proteomics of esophageal squamous cell carcinoma for novel biomarker discovery,” Cancer Biology & Therapy, vol. 12, no. 6, pp. 510–522, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. H.-H. Cao, S.-Y. Zhang, J.-H. Shen et al., “A three-protein signature and clinical outcome in esophageal squamous cell carcinoma,” Oncotarget, vol. 6, no. 7, pp. 5435–5448, 2015. View at Google Scholar
  106. Q. Tang, Q. Ji, Y. Tang et al., “Mitochondrial translocation of cofilin-1 promotes apoptosis of gastric cancer BGC-823 cells induced by ursolic acid,” Tumor Biology, vol. 35, no. 3, pp. 2451–2459, 2014. View at Publisher · View at Google Scholar · View at Scopus
  107. J. Zhang, J. Wang, Q. Guo et al., “LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells,” Cancer letters, vol. 317, no. 1, Article ID 7749944, pp. 24–32, 2012. View at Google Scholar
  108. D. Nowak, A. J. Mazur, A. Popow-Woźniak, A. Radwańska, H. G. Mannherz, and M. Malicka-Błaszkiewicz, “Subcellular distribution and expression of cofilin and ezrin in human colon adenocarcinoma cell lines with different metastatic potential,” European Journal of Histochemistry, vol. 54, no. 2, pp. 59–66, 2010. View at Google Scholar · View at Scopus
  109. A. Popow-Woźniak, A. J. Mazur, H. G. Mannherz, M. Malicka-Blaszkiewicz, and D. Nowak, “Cofilin overexpression affects actin cytoskeleton organization and migration of human colon adenocarcinoma cells,” Histochemistry and Cell Biology, vol. 138, no. 5, pp. 725–736, 2012. View at Publisher · View at Google Scholar · View at Scopus
  110. Y. Zhou, J. Su, L. Shi, Q. Liao, and Q. Su, “DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion,” Oncology Reports, vol. 29, no. 2, pp. 605–612, 2013. View at Publisher · View at Google Scholar · View at Scopus
  111. V. Subramaniam, I. R. Vincent, and S. Jothy, “Upregulation and dephosphorylation of cofilin: modulation by CD44 variant isoform in human colon cancer cells,” Experimental and Molecular Pathology, vol. 79, no. 3, pp. 187–193, 2005. View at Publisher · View at Google Scholar · View at Scopus
  112. S.-J. Ding, Y. Li, X.-X. Shao et al., “Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials,” Proteomics, vol. 4, no. 4, pp. 982–994, 2004. View at Publisher · View at Google Scholar · View at Scopus
  113. Y. Wang, Y. Kuramitsu, T. Ueno et al., “Differential expression of up-regulated cofilin-1 and down-regulated cofilin-2 characteristic of pancreatic cancer tissues,” Oncology Reports, vol. 26, no. 6, pp. 1595–1599, 2011. View at Publisher · View at Google Scholar · View at Scopus
  114. M. M. Schittenhelm, S. Shiraga, A. Schroeder et al., “Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies,” Cancer Research, vol. 66, no. 1, pp. 473–481, 2006. View at Publisher · View at Google Scholar · View at Scopus
  115. F. Petti, A. Thelemann, J. Kahler et al., “Temporal quantitation of mutant Kit tyrosine kinase signaling attenuated by a novel thiophene kinase inhibitor OSI-930,” Molecular Cancer Therapeutics, vol. 4, no. 8, pp. 1186–1197, 2005. View at Publisher · View at Google Scholar · View at Scopus
  116. B. Yan, C. T. Yap, S. Wang et al., “Cofilin immunolabelling correlates with depth of invasion in gastrointestinal endocrine cell tumors,” Acta Histochemica, vol. 112, no. 1, pp. 101–106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  117. B. J. Nolen, N. Tomasevic, A. Russell et al., “Characterization of two classes of small molecule inhibitors of Arp2/3 complex,” Nature, vol. 460, no. 7258, pp. 1031–1034, 2009. View at Publisher · View at Google Scholar · View at Scopus
  118. J. R. Peterson, L. C. Bickford, D. Morgan et al., “Chemical inhibition of N-WASP by stabilization of a native autoinhibited conformation,” Nature Structural & Molecular Biology, vol. 11, no. 8, pp. 747–755, 2004. View at Publisher · View at Google Scholar · View at Scopus
  119. S. Liebau, J. Steinestel, L. Linta et al., “An SK3 channel/nWASP/Abi-1 complex is involved in early neurogenesis,” PLoS ONE, vol. 6, no. 3, Article ID e18148, 2011. View at Publisher · View at Google Scholar · View at Scopus
  120. E. Serrano-Pertierra, E. Cernuda-Morollón, and C. López-Larrea, “Wiskott-Aldrich syndrome protein (WASp) and N-WASp are involved in the regulation of NK-cell migration upon NKG2D activation,” European Journal of Immunology, vol. 42, no. 8, pp. 2142–2151, 2012. View at Publisher · View at Google Scholar · View at Scopus
  121. R. Ganeshan, K. Nowotarski, A. Di, D. J. Nelson, and K. L. Kirk, “CFTR surface expression and chloride currents are decreased by inhibitors of N-WASP and actin polymerization,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1773, no. 2, pp. 192–200, 2007. View at Publisher · View at Google Scholar · View at Scopus
  122. T. G. Oertner and A. Matus, “Calcium regulation of actin dynamics in dendritic spines,” Cell Calcium, vol. 37, no. 5, pp. 477–482, 2005. View at Publisher · View at Google Scholar · View at Scopus
  123. A. K. Howe, “Cross-talk between calcium and protein kinase A in the regulation of cell migration,” Current Opinion in Cell Biology, vol. 23, no. 5, pp. 554–561, 2011. View at Publisher · View at Google Scholar · View at Scopus
  124. A. Escudero-Esparza, W. G. Jiang, and T. A. Martin, “Claudin-5 is involved in breast cancer cell motility through the N-WASP and ROCK signalling pathways,” Journal of Experimental and Clinical Cancer Research, vol. 31, no. 1, article 43, 2012. View at Publisher · View at Google Scholar · View at Scopus
  125. J. R. Peterson, R. S. Lokey, T. J. Mitchison, and M. W. Kirschner, “A chemical inhibitor of N-WASP reveals a new mechanism for targeting protein interactions,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 19, pp. 10624–10629, 2001. View at Publisher · View at Google Scholar · View at Scopus
  126. J. R. Peterson and E. A. Golemis, “Autoinhibited proteins as promising drug targets,” Journal of Cellular Biochemistry, vol. 93, no. 1, pp. 68–73, 2004. View at Publisher · View at Google Scholar · View at Scopus
  127. T. Kawamura, M. Kitagawa, and M. Imoto, “Chemical biology of cell motility inhibitors,” Protein Targeting with Small Molecules: Chemical Biology Techniques and Applications, pp. 169–187, 2009. View at Publisher · View at Google Scholar · View at Scopus
  128. L. Chen, S. Yang, J. Jakoncic, J. J. Zhang, and X.-Y. Huang, “Migrastatin analogues target fascin to block tumour metastasis,” Nature, vol. 464, no. 7291, pp. 1062–1066, 2010. View at Publisher · View at Google Scholar · View at Scopus
  129. S. M. Keezer, S. E. Ivie, H. C. Krutzsch, A. Tandle, S. K. Libutti, and D. D. Roberts, “Angiogenesis inhibitors target the endothelial cell cytoskeleton through altered regulation of heat shock protein 27 and cofilin,” Cancer Research, vol. 63, no. 19, pp. 6405–6412, 2003. View at Google Scholar · View at Scopus
  130. K. Nagaishi, R. Adachi, S. Matsui, T. Yamaguchi, T. Kasahara, and K. Suzuki, “Herbimycin A inhibits both dephosphorylation and translocation of cofilin induced by opsonized zymosan in macrophagelike U937 cells,” Journal of Cellular Physiology, vol. 180, no. 3, pp. 345–354, 1999. View at Publisher · View at Google Scholar · View at Scopus